Physician profile
Beatrice Hecker
NPI 1770506156
$311.75
in general payments reported to CMS, 2019-2025
12 companies · $23.31 in 2025
The $23.31 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.95 · 2020: $96.29 · 2021: $82.48 · 2022: $12.00 · 2023: $21.08 · 2024: $43.64 · 2025: $23.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $88.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $88.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $76.63 | 2020 | |
| Exeltis, USA INC. | $66.79 | 2023-2025 | Slynd, Tyblume |
| Abbvie INC. | $47.72 | 2021 | |
| Therapeuticsmd, INC. | $34.84 | 2019-2020 | |
| Ascend Therapeutics US, LLC | $24.00 | 2021-2022 | |
| Evofem Biosciences, INC. | $22.76 | 2021 | |
| Janssen Biotech, INC. | $21.24 | 2024 | Tremfya, Stelara, Simponi |
| Lilly USA, LLC | $17.77 | 2019 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beatrice Hecker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.